Clinical Trial Update: Effect of Recombinant Human Growth Hormone Injection on the Clinical Outcome of POR in Patients Undergoing IVF/ET

View source ↗

Summary

This clinical trials entry reports a study evaluating whether recombinant human growth hormone injections affect outcomes in poor ovarian responders undergoing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poor Ovarian Response

Drugs mentioned

• Recombinant human growth hormone (somatropin)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Poor Ovarian Response | Status: UNKNOWN